Floatz logo

Bosentan

Digital Ulcer

Elpen Pharmaceutical Co. Inc.Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Digital Ulcer cohort.

Asset / SponsorPhaseRating
VARINON
Primus Pharmaceuticals
N/AD

Same molecule, other indications

Bosentan is also rated in:

systemic sclerosisDormant
B
Indicative ·
63 / 100
View asset →
SclerodermaDormant
B
Indicative ·
63 / 100
View asset →
idiopathic pulmonary fibrosisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →